BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 10893290)

  • 1. Telomerase activity and telomerase subunits gene expression patterns in neuroblastoma: a molecular and immunohistochemical study establishing prognostic tools for fresh-frozen and paraffin-embedded tissues.
    Poremba C; Scheel C; Hero B; Christiansen H; Schaefer KL; Nakayama Ji; Berthold F; Juergens H; Boecker W; Dockhorn-Dworniczak B
    J Clin Oncol; 2000 Jul; 18(13):2582-92. PubMed ID: 10893290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Full-length telomerase reverse transcriptase messenger RNA is an independent prognostic factor in neuroblastoma.
    Krams M; Hero B; Berthold F; Parwaresch R; Harms D; Rudolph P
    Am J Pathol; 2003 Mar; 162(3):1019-26. PubMed ID: 12598334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Relationship among telomerase activity, telomerase RNA and telomerase catalytic subunit gene expression and their significance in non small-cell lung cancer].
    Wang J; Liu X; Jiang W
    Zhonghua Zhong Liu Za Zhi; 2001 Jul; 23(4):289-92. PubMed ID: 11783109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telomerase activity distinguishes between neuroblastomas with good and poor prognosis.
    Poremba C; Willenbring H; Hero B; Christiansen H; Schäfer KL; Brinkschmidt C; Jürgens H; Böcker W; Dockhorn-Dworniczak B
    Ann Oncol; 1999 Jun; 10(6):715-21. PubMed ID: 10442195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of telomerase activity by alternate splicing of human telomerase reverse transcriptase mRNA in a subset of neuroblastomas.
    Krams M; Claviez A; Heidorn K; Krupp G; Parwaresch R; Harms D; Rudolph P
    Am J Pathol; 2001 Nov; 159(5):1925-32. PubMed ID: 11696453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Traditional and emerging molecular markers in neuroblastoma prognosis: the good, the bad and the ugly.
    Poremba C; Hero B; Goertz HG; Scheel C; Wai D; Schaefer KL; Christiansen H; Berthold F; Juergens H; Boecker W; Dockhorn-Dworniczak B
    Klin Padiatr; 2001; 213(4):186-90. PubMed ID: 11528552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telomerase as a prognostic marker in breast cancer: high-throughput tissue microarray analysis of hTERT and hTR.
    Poremba C; Heine B; Diallo R; Heinecke A; Wai D; Schaefer KL; Braun Y; Schuck A; Lanvers C; Bànkfalvi A; Kneif S; Torhorst J; Zuber M; Köchli OR; Mross F; Dieterich H; Sauter G; Stein H; Fogt F; Boecker W
    J Pathol; 2002 Oct; 198(2):181-9. PubMed ID: 12237877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telomerase is a strong indicator for assessing the proneness to progression in neuroblastomas.
    Poremba C; Hero B; Heine B; Scheel C; Schaefer KL; Christiansen H; Berthold F; Kneif S; Stein H; Juergens H; Boecker W; Dockhorn-Dworniczak B
    Med Pediatr Oncol; 2000 Dec; 35(6):651-5. PubMed ID: 11107139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telomerase components as a diagnostic tool in human oral lesions.
    Sumida T; Hamakawa H; Sogawa K; Sugita A; Tanioka H; Ueda N
    Int J Cancer; 1999 Jan; 80(1):1-4. PubMed ID: 9935220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between telomerase activity and outcome in patients with nonmetastatic Ewing family of tumors.
    Ohali A; Avigad S; Cohen IJ; Meller I; Kollender Y; Issakov J; Gelernter I; Goshen Y; Yaniv I; Zaizov R
    J Clin Oncol; 2003 Oct; 21(20):3836-43. PubMed ID: 14551302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid detection of MYCN gene amplification and telomerase expression in neuroblastoma.
    Hiyama E; Hiyama K; Yokoyama T; Fukuba I; Yamaoka H; Shay JW; Matsuura Y
    Clin Cancer Res; 1999 Mar; 5(3):601-9. PubMed ID: 10100712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of B-myb in neuroblastoma tumors is a poor prognostic factor independent from MYCN amplification.
    Raschellà G; Cesi V; Amendola R; Negroni A; Tanno B; Altavista P; Tonini GP; De Bernardi B; Calabretta B
    Cancer Res; 1999 Jul; 59(14):3365-8. PubMed ID: 10416595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid detection of telomerase expression of neuroblastoma in paraffin-embedded tissue: combination of in situ hybridisation and quantitative PCR.
    Zhao M; Guan Z; Gong L; Liu F; Gu W; Liu L; Jiang K; Cai J; Feng C; Kuick CH; Chang KTE; Wang J; Tang H; Yin M; Mao J
    Pathology; 2023 Dec; 55(7):958-965. PubMed ID: 37741703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of MYCN oncogene expression in childhood neuroblastoma.
    Bordow SB; Norris MD; Haber PS; Marshall GM; Haber M
    J Clin Oncol; 1998 Oct; 16(10):3286-94. PubMed ID: 9779703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of inhibitor-of-apoptosis protein (IAP) livin by neuroblastoma cells: correlation with prognostic factors and outcome.
    Kim DK; Alvarado CS; Abramowsky CR; Gu L; Zhou M; Soe MM; Sullivan K; George B; Schemankewitz E; Findley HW
    Pediatr Dev Pathol; 2005; 8(6):621-9. PubMed ID: 16328668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telomerase activity in human hepatocellular carcinoma: parallel correlation with human telomerase reverse transcriptase (hTERT) mRNA isoform expression but not with cell cycle modulators or c-Myc expression.
    Chen CJ; Tsai NM; Liu YC; Ho LI; Hsieh HF; Yen CY; Harn HJ
    Eur J Surg Oncol; 2002 Apr; 28(3):225-34. PubMed ID: 11944954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telomerase activity as a prognostic factor in neuroblastomas.
    Streutker CJ; Thorner P; Fabricius N; Weitzman S; Zielenska M
    Pediatr Dev Pathol; 2001; 4(1):62-7. PubMed ID: 11200492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telomerase activity by TRAP assay and telomerase RNA (hTR) expression are predictive of outcome in neuroblastoma.
    Choi LM; Kim NW; Zuo JJ; Gerbing R; Stram D; Lukens JN; Matthay KK; Seeger RC; Reynolds CP
    Med Pediatr Oncol; 2000 Dec; 35(6):647-50. PubMed ID: 11107138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of human telomerase subunits and correlation with telomerase activity in cervical cancer.
    Takakura M; Kyo S; Kanaya T; Tanaka M; Inoue M
    Cancer Res; 1998 Apr; 58(7):1558-61. PubMed ID: 9537264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of telomerase and its associate genes expression in the maintenance of telomere length in squamous cell carcinoma of the esophagus.
    Hsu CP; Lee LW; Shai SE; Chen CY
    World J Gastroenterol; 2005 Nov; 11(44):6941-7. PubMed ID: 16437597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.